Unknown

Dataset Information

0

Circulating tumor DNA predicts recurrence and assesses prognosis in operable gastric cancer: A systematic review and meta-analysis

ABSTRACT:

SUBMITTER: Mi J 

PROVIDER: S-EPMC10695564 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Residual circulating tumor DNA after adjuvant chemotherapy effectively predicts recurrence of stage II-III gastric cancer.
| S-EPMC10693304 | biostudies-literature
Unknown Deep sequencing of circulating tumor DNA detects molecular residual disease and predicts recurrence in gastric cancer.
| S-EPMC7214415 | biostudies-literature
Unknown Limited Sensitivity of Circulating Tumor DNA Detection by Droplet Digital PCR in Non-Metastatic Operable Gastric Cancer Patients.
| S-EPMC6468548 | biostudies-literature
Unknown Circulating tumor DNA predicts prognosis at different time points in patients with esophageal cancer: a systematic review and meta-analysis.
| S-EPMC12507613 | biostudies-literature
Unknown Circulating tumor DNA analysis predicts recurrence and avoids unnecessary adjuvant chemotherapy in I-IV colorectal cancer.
| S-EPMC10822076 | biostudies-literature
Unknown Monitoring circulating tumor DNA by analyzing personalized cancer-specific rearrangements to detect recurrence in gastric cancer.
| S-EPMC6802636 | biostudies-literature
Unknown The diagnostic and prognostic usage of circulating tumor DNA in operable hepatocellular carcinoma.
| S-EPMC6834494 | biostudies-literature
Unknown Personalized mutation tracking in circulating-tumor DNA predicts recurrence in patients with high-risk early breast cancer.
| S-EPMC12181414 | biostudies-literature
Unknown Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic Adenocarcinoma.
| S-EPMC4936958 | biostudies-literature
Unknown Analysis of Circulating Tumor DNA to Predict Risk of Recurrence in Patients With Esophageal and Gastric Cancers.
| S-EPMC10530958 | biostudies-literature